Imbalance in the RAAS and KKS (caused primarily by loss of ACE2 activity in patients with COVID-19 are contributing factors to consequent deregulation of blood pressure), loss of protective effects, organ damage and exacerbated tissue and systemic inflammation, among others, are key factors that may explain the severity of the disease. Here, ACE2 is linked to COVID-19.